Paper14616995
Role of the microenvironment in chronic lymphocytic leukaemia.
Caligaris-Cappio F. Br J Haematol, 2003. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. Role of the microenvironment in chronic lymphocytic leukaemia. Papers, record 14616995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14616995
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| Leukemia, Lymphocytic, Chronic, B-Cell | Major topic |
| Lymphocyte Activation | Major topic |
| Models, Immunological | Major topic |
| CD40 Ligand | |
| Cell Division | |
| Disease Progression | |
| Humans | |
| Immunotherapy, Adoptive | |
| Stromal Cells |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39474602 | CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/39474602 | PubMed |
| 37681023 | Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review. | Front Oncol | 2023 | https://conductscience.org/library/papers/37681023 | PubMed |
| 36714146 | Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36714146 | PubMed |
| 36420268 | CD160 receptor in CLL: Current state and future avenues. | Front Immunol | 2022 | https://conductscience.org/library/papers/36420268 | PubMed |
| 35871396 | Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia. | Eur J Haematol | 2022 | https://conductscience.org/library/papers/35871396 | PubMed |
| 34041018 | AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression. | Front Oncol | 2021 | https://conductscience.org/library/papers/34041018 | PubMed |
| 33833385 | Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia. | Leukemia | 2021 | https://conductscience.org/library/papers/33833385 | PubMed |
| 33418996 | Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33418996 | PubMed |
| 33228048 | Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells. | Biomedicines | 2020 | https://conductscience.org/library/papers/33228048 | PubMed |
| 33148933 | Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies. | J Clin Exp Hematop | 2020 | https://conductscience.org/library/papers/33148933 | PubMed |
| 32055920 | Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia. | Cancer Immunol Immunother | 2020 | https://conductscience.org/library/papers/32055920 | PubMed |
| 30679590 | BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo. | Sci Rep | 2019 | https://conductscience.org/library/papers/30679590 | PubMed |
| 30642077 | Hepatocyte Growth Factor: A Microenvironmental Resource for Leukemic Cell Growth. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30642077 | PubMed |
| 30310786 | Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations. | Blood Res | 2018 | https://conductscience.org/library/papers/30310786 | PubMed |
| 28356875 | Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia. | J Med Biochem | 2016 | https://conductscience.org/library/papers/28356875 | PubMed |
| 27347068 | Granulocyte colony-stimulating factor inhibits CXCR4/SDF-1α signaling and overcomes stromal-mediated drug resistance in the HL-60 cell line. | Exp Ther Med | 2016 | https://conductscience.org/library/papers/27347068 | PubMed |
| 26065479 | CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies? | Immunotherapy | 2015 | https://conductscience.org/library/papers/26065479 | PubMed |
| 24859880 | SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders. | Haematologica | 2014 | https://conductscience.org/library/papers/24859880 | PubMed |
| 24859274 | Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor. | PLoS One | 2014 | https://conductscience.org/library/papers/24859274 | PubMed |
| 24618734 | Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein. | Leukemia | 2014 | https://conductscience.org/library/papers/24618734 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14616995
GET https://conductscience.org/api/papers/v1/14616995/cited_by?page=2